Mirae Asset Global Etfs Holdings Ltd. Syndax Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 56,842 shares of SNDX stock, worth $634,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,842
Previous 53,748
5.76%
Holding current value
$634,356
Previous $710,000
1.69%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SNDX
# of Institutions
240Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$95.1 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$88.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$54.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$47 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$44.7 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $631M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...